{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:15:49Z","timestamp":1790367349132,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sclerosing cholangitis in critically ill patients (SC-CIP) is a progressive cholestatic disease of unknown aetiology characterized by chronic biliary infections. Hence we hypothesized that common <jats:italic>NOD2<\/jats:italic> (nucleotide-binding oligomerisation domain containing 2) gene variants, known risk factors for Crohn\u2019s disease and bacterial translocation in liver cirrhosis, increase the odds of developing SC-CIP. Screening of 4,641 endoscopic retrograde cholangiography procedures identified 17 patients with SC-CIP, who were then genotyped for the three common <jats:italic>NOD2<\/jats:italic> mutations (Cohort 1, discovery cohort). To validate the association, we subsequently tested these <jats:italic>NOD2<\/jats:italic> variants in 29 patients from SC-CIP cohorts of three additional medical centers (Cohort 2, replication cohort). In Cohort 1, the <jats:italic>NOD2<\/jats:italic> variants were present in 5 of 17 SC-CIP patients (29.4%), which is twice the frequency of the general population. These results were replicated in Cohort 2 with 8 patients (27.6%) showing <jats:italic>NOD2<\/jats:italic> mutations. In contrast, polymorphisms of hepatocanalicular transporter genes did not have major impact on SC-CIP risk. This first study on genetic susceptibility in SC-CIP patients shows an extraordinary high frequency of <jats:italic>NOD2<\/jats:italic> variation, pointing to a critical role of inherited impaired anti-bacterial defense in the development of this devastating biliary disease.<\/jats:p>","DOI":"10.1038\/s41598-017-06268-y","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T16:13:20Z","timestamp":1501085600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Christoph","family":"J\u00fcngst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5508-8271","authenticated-orcid":false,"given":"Vanessa","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias C.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne N.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ofner-Ziegenfu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Voigtl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Spindelb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele I.","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim O.","family":"Lankisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"6268_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrgastro.2009.46","volume":"6","author":"P Ruemmele","year":"2009","unstructured":"Ruemmele, P., Hofstaedter, F. & Gelbmann, C. M. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol \n                           6, 287\u2013295 (2009).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6268_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","volume":"102","author":"CM Gelbmann","year":"2007","unstructured":"Gelbmann, C. M. et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol \n                           102, 1221\u20131229 (2007).","journal-title":"Am J Gastroenterol"},{"key":"6268_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000431031","volume":"31","author":"GI Kirchner","year":"2015","unstructured":"Kirchner, G. I. & Rummele, P. Update on Sclerosing Cholangitis in Critically Ill Patients. Viszeralmedizin \n                           31, 178\u2013184 (2015).","journal-title":"Viszeralmedizin"},{"key":"6268_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/00365521.2010.537683","volume":"46","author":"GI Kirchner","year":"2011","unstructured":"Kirchner, G. I. et al. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scand J Gastroenterol \n                           46, 471\u2013478 (2011).","journal-title":"Scand J Gastroenterol"},{"key":"6268_CR5","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/lt.24192","volume":"21","author":"T Voigtl\u00e4nder","year":"2015","unstructured":"Voigtl\u00e4nder, T., Jaeckel, E., Lehner, F., Manns, M. P. & Lankisch, T. O. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications. Liver Transpl \n                           21, 1295\u20131299 (2015).","journal-title":"Liver Transpl"},{"key":"6268_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1055\/s-0032-1325733","volume":"44","author":"T Voigtlander","year":"2012","unstructured":"Voigtl\u00e4nder, T. et al. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy \n                           44, 1055\u20131058 (2012).","journal-title":"Endoscopy"},{"key":"6268_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/labinvest.3700716","volume":"88","author":"M Body-Malapel","year":"2008","unstructured":"Body-Malapel, M. et al. NOD2: a potential target for regulating liver injury. Lab Invest \n                           88, 318\u2013327 (2008).","journal-title":"Lab Invest"},{"key":"6268_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/gut.52.11.1591","volume":"52","author":"Y Ogura","year":"2003","unstructured":"Ogura, Y. et al. Expression of NOD2 in Paneth cells: a possible link to Crohn\u2019s ileitis. Gut \n                           52, 1591\u20131597 (2003).","journal-title":"Gut"},{"key":"6268_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2010.04.026","volume":"53","author":"MJ Scott","year":"2010","unstructured":"Scott, M. J., Chen, C., Sun, Q. & Billiar, T. R. Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. J Hepatol \n                           53, 693\u2013701 (2010).","journal-title":"J Hepatol"},{"key":"6268_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"KS Kobayashi","year":"2005","unstructured":"Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science \n                           307, 731\u2013734 (2005).","journal-title":"Science"},{"key":"6268_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature \n                           536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"6268_CR12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1572-0241.2007.01149.x","volume":"102","author":"JP Hugot","year":"2007","unstructured":"Hugot, J. P. et al. Prevalence of CARD15\/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol \n                           102, 1259\u20131267 (2007).","journal-title":"Am J Gastroenterol"},{"key":"6268_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(00)05063-7","volume":"357","author":"J Hampe","year":"2001","unstructured":"Hampe, J. et al. Association between insertion mutation in NOD2 gene and Crohn\u2019s disease in German and British populations. Lancet \n                           357, 1925\u20131928 (2001).","journal-title":"Lancet"},{"key":"6268_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature \n                           411, 599\u2013603 (2001).","journal-title":"Nature"},{"key":"6268_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/hep.23440","volume":"51","author":"B Appenrodt","year":"2010","unstructured":"Appenrodt, B. et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology \n                           51, 1327\u20131333 (2010).","journal-title":"Hepatology"},{"key":"6268_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"AP Cuthbert","year":"2002","unstructured":"Cuthbert, A. P. et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology \n                           122, 867\u2013874 (2002).","journal-title":"Gastroenterology"},{"key":"6268_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","volume":"359","author":"J Hampe","year":"2002","unstructured":"Hampe, J. et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn\u2019s disease: a cohort study. Lancet \n                           359, 1661\u20131665 (2002).","journal-title":"Lancet"},{"key":"6268_CR18","doi-asserted-by":"publisher","first-page":"e72617","DOI":"10.1371\/journal.pone.0072617","volume":"8","author":"M Janse","year":"2013","unstructured":"Janse, M. et al. Recipient\u2019s genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation. PLoS One \n                           8, e72617 (2013).","journal-title":"PLoS One"},{"key":"6268_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2015.01.013","volume":"70","author":"T Voigtl\u00e4nder","year":"2015","unstructured":"Voigtl\u00e4nder, T. et al. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. J Infect \n                           70, 483\u2013490 (2015).","journal-title":"J Infect"},{"key":"6268_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00134-007-0722-z","volume":"33","author":"J Brenmoehl","year":"2007","unstructured":"Brenmoehl, J. et al. Genetic variants in the NOD2\/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med \n                           33, 1541\u20131548 (2007).","journal-title":"Intensive Care Med"},{"key":"6268_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jhep.2014.02.012","volume":"60","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. J Hepatol \n                           60, 1259\u20131267 (2014).","journal-title":"J Hepatol"},{"key":"6268_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","volume":"102","author":"TH Karlsen","year":"2007","unstructured":"Karlsen, T. H. et al. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol \n                           102, 115\u2013121 (2007).","journal-title":"Am J Gastroenterol"},{"key":"6268_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2350-9-81","volume":"9","author":"P Gaj","year":"2008","unstructured":"Gaj, P., Habior, A., Mikula, M. & Ostrowski, J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn\u2019s disease in Polish patients. BMC Med Genet \n                           9, 81 (2008).","journal-title":"BMC Med Genet"},{"key":"6268_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger, R. P. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med \n                           41, 580\u2013637 (2013).","journal-title":"Crit Care Med"},{"key":"6268_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1517\/14656566.2016.1145663","volume":"17","author":"K Yan","year":"2016","unstructured":"Yan, K. & Garcia-Tsao, G. Novel prevention strategies for bacterial infections in cirrhosis. Expert Opin Pharmacother \n                           17, 689\u2013701 (2016).","journal-title":"Expert Opin Pharmacother"},{"key":"6268_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature17631","volume":"532","author":"AM Keestra-Gounder","year":"2016","unstructured":"Keestra-Gounder, A. M. et al. NOD1 and NOD2 signalling links ER stress with inflammation. Nature \n                           532, 394\u2013397 (2016).","journal-title":"Nature"},{"key":"6268_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.15252\/emmm.201404169","volume":"7","author":"E Denou","year":"2015","unstructured":"Denou, E. et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol Med \n                           7, 259\u2013274 (2015).","journal-title":"EMBO Mol Med"},{"key":"6268_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2014.11.027","volume":"62","author":"Y Nakanuma","year":"2015","unstructured":"Nakanuma, Y., Sasaki, M. & Harada, K. Autophagy and senescence in fibrosing cholangiopathies. J Hepatol \n                           62, 934\u2013945 (2015).","journal-title":"J Hepatol"},{"key":"6268_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","volume":"133","author":"SW Van Mil","year":"2007","unstructured":"Van Mil, S. W. et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology \n                           133, 507\u2013516 (2007).","journal-title":"Gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06268-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:48:20Z","timestamp":1671781700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06268-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6268"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06268-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]},"assertion":[{"value":"7 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7026"}}